There are 702 resources available
Treatment of localised tumours
Presenter: Maria Elisa Reig Monzon
Session: Hepatocellular cancer
Resources:
Slides
Webcast
Q&A
Session: Hepatocellular cancer
Resources:
Webcast
Introduction
Presenter: Julien Taieb
Session: Servier - Perspectives on the current and future management of mCRC: Consensus and controversies
Resources:
Webcast
New perspectives in the 1st and 2nd line treatment landscape of mCRC
Presenter: Jenny Seligmann
Session: Servier - Perspectives on the current and future management of mCRC: Consensus and controversies
Resources:
Webcast
Panel discussion
Presenter: Julien Taieb
Session: Servier - Perspectives on the current and future management of mCRC: Consensus and controversies
Resources:
Webcast
Optimising treatment options in 3rd line and beyond
Presenter: Dominik Modest
Session: Servier - Perspectives on the current and future management of mCRC: Consensus and controversies
Resources:
Webcast
Panel discussion
Presenter: Julien Taieb
Session: Servier - Perspectives on the current and future management of mCRC: Consensus and controversies
Resources:
Webcast
Conclusion
Presenter: Sara Lonardi
Session: Servier - Perspectives on the current and future management of mCRC: Consensus and controversies
Resources:
Webcast
1O - Chemotherapy and liver transplantation versus chemotherapy alone in patients with definitively unresectable colorectal liver metastases: Updated results from the randomized TRANSMET trial
Presenter: Maximiliano Gelli
Session: Proffered Paper session
Resources:
Abstract
Slides
Webcast
2O - Health-related quality of life (HRQoL) with first-line (1L) nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) in patients (pts) with microsatellite instability-high (MSI-H)/mismatch repair-deficient (dMMR) metastatic colorectal cancer (mCRC):
Presenter: Sara Lonardi
Session: Proffered Paper session
Resources:
Abstract
Slides
Webcast